CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 3.1% Following Weak Earnings
10 May 17:24 · 4 articles
S4 Capital sees sales fall by a fifth after warning over advertising slump
10 May 10:23 · 3 articles